Mealey's (September 9, 2022, 4:20 PM EDT) -- NEWARK, N.J. — Novo Nordisk Inc. on Aug. 30 agreed to pay $6.3 million to settle allegations that it violated the False Claims Act by selling needles that were manufacturer in “non-designated” countries in violation of the Trade Agreements Act, according to a settlement released by the U.S. attorney for the District of New Jersey....